Gynecologic Oncology Group
Clinical trials sponsored by Gynecologic Oncology Group, explained in plain language.
-
New drug duo aims to halt endometrial cancer growth
Disease control OngoingThis study tests a combination of two drugs, abemaciclib and letrozole, in people with advanced or recurrent endometrioid endometrial cancer that cannot be cured by surgery or radiation. The main goal is to see how many participants have no cancer growth after 6 months of treatme…
Phase: PHASE2 • Sponsor: Gynecologic Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug combo shows promise for Hard-to-Treat ovarian cancer
Disease control OngoingThis phase II trial is testing whether the combination of ribociclib (a targeted cancer drug) and letrozole (a hormone therapy) can shrink or stabilize tumors in women with recurrent low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. The study enrolled 51 wom…
Phase: PHASE2 • Sponsor: Gynecologic Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC